Literature DB >> 30849642

Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling.

Xixia Zhang1, Jing Yang1, Zhigang Bian1, Dong Shi1, Zhiwei Cao2.   

Abstract

Nasopharyngeal carcinoma (NPC) is the most common type of malignancy of the neck and head in Southeast Asia and North Africa. Long noncoding RNA (LncRNA) Differentiation antagonizing nonprotein coding RNA (DANCR) has been reported to exert oncogenic functions in various malignant tumors. However, whether DANCR is involved in NPC tumorgenesis and its underlying mechanisms are still unknown. In the current study, we investigated the expression and biological functions of DANCR in NPC cells and found that DANCR is highly expressed in NPC cells and IL-6 stimulation upregulates DANCR expression through an STAT3-dependent manner. Besides, DANCR knockdown attenuates IL-6-induced proliferation and invasion of NPC cells. Furthermore, DANCR specifically interacts with STAT3 to promote STAT3 activation in NPC cells. Moreover, DANCR knockdown evidently decreases IL-6 induced the association between STAT3 and JAK1 in NPC cells. In addition, we also found that DANCR also indirectly binds to JAK1 through interacting with STAT3 under IL-6 stimulation in NPC cells. Taken together, the present study for the first time demonstrates that DANCR, acting as an oncogene in NPC, promotes NPC progression by interacting with STAT3 and enhancing JAK1 binding to STAT3 to strengthen IL-6/JAK1/STAT3 signaling, suggesting that it may be a potential target to be used as a novel strategy to develop NPC therapeutics.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Differentiation antagonizing nonprotein coding RNA; Interleukin-6; Nasopharyngeal carcinoma; Signal transducer and activator of transcription 3

Mesh:

Substances:

Year:  2019        PMID: 30849642     DOI: 10.1016/j.biopha.2019.108713

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.

Authors:  Chanan Meydan; Nimrod Madrer; Hermona Soreq
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

Review 2.  Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications.

Authors:  Yao Tang; Xiusheng He
Journal:  Mol Cell Biochem       Date:  2021-05-17       Impact factor: 3.396

3.  [Interference of long noncoding RNA FOXCUT inhibits epithelial-mesenchymal transformation and induces mitochondrial injury in nasopharyngeal carcinoma cells].

Authors:  L Gao; X Zhang; S Dou; X Yue; J Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-08-31

Review 4.  The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology.

Authors:  Vivek Sharma
Journal:  Mol Biol Rep       Date:  2022-07-24       Impact factor: 2.742

5.  TET2 suppresses nasopharyngeal carcinoma progression by inhibiting glycolysis metabolism.

Authors:  Xixia Zhang; Jing Yang; Dong Shi; Zhiwei Cao
Journal:  Cancer Cell Int       Date:  2020-08-03       Impact factor: 5.722

6.  LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells.

Authors:  Yuan Liu; Lamei Chen; Huabing Yuan; Shenghong Guo; Gang Wu
Journal:  Onco Targets Ther       Date:  2020-02-05       Impact factor: 4.147

7.  Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression.

Authors:  Jincheng Zeng; Shasha Chen; Caihong Li; Ziyu Ye; Bihua Lin; Yanfang Liang; Bin Wang; Yan Ma; Xingxing Chai; Xin Zhang; Keyuan Zhou; Qunzhou Zhang; Haitao Zhang
Journal:  J Cancer       Date:  2020-02-03       Impact factor: 4.207

8.  LINC00958 Promotes The Malignancy Of Nasopharyngeal Carcinoma By Sponging microRNA-625 And Thus Upregulating NUAK1.

Authors:  Meijuan Chen; Zhina Xu; Yingyao Zhang; Xiujuan Zhang
Journal:  Onco Targets Ther       Date:  2019-11-06       Impact factor: 4.147

Review 9.  Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers.

Authors:  Shi-Jia Jin; Ming-Zhu Jin; Bai-Rong Xia; Wei-Lin Jin
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

Review 10.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.